By KAI ICHINO/ Staff Writer
September 28, 2021 at 18:10 JST
Sotrovimab, a COVID-19 drug developed by GlaxoSmithKline K.K. (Provided by GlaxoSmithKline K.K.)
The health ministry granted fast-track approval for a neutralizing antibody on Sept. 27, making it the second COVID-19 treatment available in Japan for patients with mild symptoms. [Read More]
A peek through the music industry’s curtain at the producers who harnessed social media to help their idols go global.
A series based on diplomatic documents declassified by Japan’s Foreign Ministry
Here is a collection of first-hand accounts by “hibakusha” atomic bomb survivors.
Cooking experts, chefs and others involved in the field of food introduce their special recipes intertwined with their paths in life.
A series about Japanese-Americans and their memories of World War II
